Mitotic Count by Phosphohistone H3 Immunohistochemical Staining Predicts Survival and Improves Interobserver Reproducibility in Well-differentiated Neuroendocrine Tumors of the Pancreas

被引:4
作者
Voss, Sarah M. [1 ]
Riley, Meghan P. [1 ]
Lokhandwala, Parvez M. [1 ]
Wang, Ming [2 ,3 ]
Yang, Zhaohai [1 ]
机构
[1] Penn State Milton S Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA
[2] Penn State Milton S Hershey Med Ctr, Dept Publ Hlth Sci, Hershey, PA 17033 USA
[3] Penn State Coll Med, Hershey, PA USA
关键词
mitosis; Ki67; antigen; gastroenteropancreatic neuroendocrine tumors; histone H3; immunohistochemistry; Kaplan-Meier estimate; proportional hazards models; PROGNOSTIC MARKERS; LABELING INDEXES; MITOSIS; KI-67; PHOSPHORYLATION; HETEROGENEITY;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Well-differentiated neuroendocrine tumors (WDNETs) of the pancreas are graded on the basis of mitotic count or Ki67 index. Mitotic count has a narrow cutoff; its assessment is time consuming and carries poor interobserver reproducibility. Phosphohistone H3 (PHH3) is a mitosis-specific marker whose value has been validated in several tumor types. We sought to assess the utility of PHH3 in histologic grading of pancreatic WDNETs. Sixty-three cases of surgically resected primary pancreatic WDNETs were retrieved, and immunohistochemical analysis for PHH3 and Ki67 was performed. Mitotic rate was independently assessed by 4 pathologists on hematoxylin and eosin (HE; in 50 high-power fields [HPFs], expressed as mitoses/10 HPF) and PHH3 stains (in 50 HPFs, one 10x, and one 20x hotspot). PHH3 and Ki67 labeling indices were determined on a single 20x hotspot and expressed as the percentage of positive cells to total cells. We found that mitotic counts by various methods significantly correlated with each other and also with PHH3 and Ki67 indices, with the best correlation seen within the 3 different PHH3 counts (in 50 HPFs, one 10x and one 20x hotspot). Moreover, mitotic count on PHH3 was less time consuming than that on HE (1.68 vs. 3.67 min for 50 HPFs, P < 0.0001). Histologic grade determined by PHH3 significantly correlated with disease-specific and disease-free survivals, with the best cutoffs of >= 4 mitoses/10HPF (2mm(2)), >= 7 mitoses/10x hotspot, >= 5 mitoses/20x hotspot (log rank test, P < 0.0001), and >= 0.16% for PHH3 labeling index (log rank test, P < 0.0006). Tumor grades based on PHH3 stain also showed significant correlation with patient survivals in multivariate Cox proportional hazards models (P < 0.05). Histologic grades by mitotic counts on PHH3 demonstrated high concordance and kappa agreement with grades determined by mitotic count on HE. PHH3 stain also showed improved interobserver agreement in both original mitotic count (intraclass correlation 0.98 vs. 0.79) and final grade assignment (Fleiss kappa 0.69 vs. 0.46) as compared with HE. Thus, our data confirmed that histologic grading by PHH3 stain has practical and prognostic values and offers reduced time and improved interobserver reproducibility in mitotic rate assessment and grade assignment. Although larger series are needed for validation, mitotic rate can potentially be determined by counting 1 hotspot, which will greatly facilitate the assessment of histologic grade in pancreatic WDNETs.
引用
收藏
页码:13 / 24
页数:12
相关论文
共 28 条
  • [11] Klimstra DS, 2013, PATHOLOGY CLASSIFICA
  • [12] Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms
    La Rosa, Stefano
    Inzani, Frediano
    Vanoli, Alessandro
    Klersy, Catherine
    Dainese, Linda
    Rindi, Guido
    Capella, Carlo
    Bordi, Cesare
    Solcia, Enrico
    [J]. HUMAN PATHOLOGY, 2011, 42 (10) : 1373 - 1384
  • [13] The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
    Lawrence, Ben
    Gustafsson, Bjorn I.
    Chan, Anthony
    Svejda, Bernhard
    Kidd, Mark
    Modlin, Irvin M.
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2011, 40 (01) : 1 - +
  • [14] Grading of Well-differentiated Pancreatic Neuroendocrine Tumors Is Improved by the Inclusion of Both Ki67 Proliferative Index and Mitotic Rate
    McCall, Chad M.
    Shi, Chanjuan
    Cornish, Toby C.
    Klimstra, David S.
    Tang, Laura H.
    Basturk, Olca
    Mun, Liew Jun
    Ellison, Trevor A.
    Wolfgang, Christopher L.
    Choti, Michael A.
    Schulick, Richard D.
    Edil, Barish H.
    Hruban, Ralph H.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (11) : 1671 - 1677
  • [15] Molenaar W M, 2000, Ann Diagn Pathol, V4, P228, DOI 10.1053/adpa.2000.8126
  • [16] Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma
    Nielsen, Patricia S.
    Riber-Hansen, Rikke
    Jensen, Trine O.
    Schmidt, Henrik
    Steiniche, Torben
    [J]. MODERN PATHOLOGY, 2013, 26 (03) : 404 - 413
  • [17] Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression
    Panzuto, Francesco
    Boninsegna, Letizia
    Fazio, Nicola
    Campana, Davide
    Brizzi, Maria Pia
    Capurso, Gabriele
    Scarpa, Aldo
    De Braud, Filippo
    Dogliotti, Luigi
    Tomassetti, Paola
    Delle Fave, Gianfranco
    Falconi, Massimo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) : 2372 - 2377
  • [18] Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
    Pape, Ulrich-Frank
    Jann, Henning
    Mueller-Nordhorn, Jacqueline
    Bockelbrink, Angelina
    Berndt, Uta
    Willich, Stefan N.
    Koch, Martin
    Roecken, Christoph
    Rindi, Guido
    Wiedenmann, Bertram
    [J]. CANCER, 2008, 113 (02) : 256 - 265
  • [19] Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours
    Ramage, JK
    Davies, AHG
    Ardill, J
    Bax, N
    Caplin, M
    Grossman, A
    Hawkins, R
    McNicol, AM
    Reed, N
    Sutton, R
    Thakker, R
    Aylwin, S
    Breen, D
    Britton, K
    Buchanan, K
    Corrie, P
    Gillams, A
    Lewington, V
    McCance, D
    Meeran, K
    Watkinson, A
    [J]. GUT, 2005, 54 : iv1 - iv16
  • [20] Grading of Neuroendocrine Tumors With Ki-67 Requires High-quality Assessment Practices
    Remes, Satu Maria
    Tuominen, Vilppu J.
    Helin, Heikki
    Isola, Jorma
    Arola, Johanna
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (09) : 1359 - 1363